article thumbnail

How Microbial Preservation Supports Quality and Safety in Compounding Pharmacies

Pharmacy Times

Mark Mulvahill, MBA, MSc, discusses the importance of microbial preservation and reference materials in pharmaceutical manufacturing and compounding pharmacies, highlighting their role in contamination control, regulatory compliance, and enhancing microbiological testing reliability.

article thumbnail

Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug

Pharmaceutical Technology

Robert Barrie June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Compounded GLP-1RA medication has become a key revenue driver for Hims & Hers’ telehealth platform. Hims & Hers’ revenue has been soaring on the back of its compounded glucagon-like peptide-1 receptor agonist (GLP-1RA) sales.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharma pollution ‘threatens world environment, health’; study

pharmaphorum

One in four of the world’s rivers are polluted with potentially toxic levels of pharma compounds, according to a new study.

article thumbnail

Legal Battles Intensify: Pharmaceutical Manufacturers' Lawsuits Targeting Compounding Pharmacies

Pharmacy Times

Analyzing the patent and trademark challenges faced by 503A compounding pharmacies.

article thumbnail

Q&A with Mrunal Jaywant: How the Discovery of Nitrosamines in Medicines Shifted the Pharmaceutical Manufacturing Landscape

Quality Matters

FDA: The FDA provided recommended AIs for over 260 NDSRIs based on predicted carcinogenic potency categorization and four NDSRIs based on compound-specific data or read-across analysis from a surrogate and recommended interim AI limits for two NDSRIs, N-nitroso-duloxetine (600 ng/day) and N-nitroso-ciprofloxacin (12,000 ng/day).

article thumbnail

Rapid pseudomonas aeruginosa detection method developed

European Pharmaceutical Review

The study used medications labelled as “sterile, oral and topical preparations, components of formulations for micro-pellicle media, re-agents, and chemical compounds for achieving selectivity, factors promoting multiplication, and inhibition factors.” aeruginosa bacteria in pure culture, mixed culture, or other research materials.

article thumbnail

Novel two-chamber setup could predict HPAPI dustiness

European Pharmaceutical Review

Processes in pharmaceutical manufacturing such as processing, milling, grinding, and mixing, are associated with the generation of dust. The compounds used in the pharmaceutical production are exposed to a wide variety of stresses. Thus, formulation dust containing HPAPIs is a major problem concerning potential exposure.

Dosage 105